Live feed
Filing
SC 13G/A
SC 13G/A0001535610-23-000018·PharmaCyte Biotech, Inc.
Schedule 13G ownership disclosure
PharmaCyte Biotech, Inc.
Security class unavailable · CUSIP: 17512X203
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 934,456
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-23-000018
- Form type
- SC 13G/A
- Filer
- PharmaCyte Biotech, Inc.
- CIK
- CIK 1157075
- Filed
- Jan 10, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership